XM does not provide services to residents of the United States of America.
M
M

Monster

News

Wall St sinks on Powell rate-cut caution, Trump cabinet picks

US STOCKS-Wall St sinks on Powell rate-cut caution, Trump cabinet picks Retail sales rise 0.4% in October, above forecasts Indexes on track for weekly losses Vaccine makers, packaged food cos fall after RFK Jr. appointment Applied Materials down after Q1 rev forecast misses estimates Indexes down: Dow 0.70%, S&P 500 1.32%, Nasdaq 2.24% Updated with final prices, volume data By Sinéad Carew and Lisa Pauline Mattackal Nov 15 (Reuters) - Wall Street's main indexes closed lower on Friday, with the
A
H
M
M
N
P
P
U
U
L

Wall St sinks on Powell rate-cut caution, Trump cabinet picks

US STOCKS-Wall St sinks on Powell rate-cut caution, Trump cabinet picks Updates to close By Sinéad Carew and Lisa Pauline Mattackal Nov 15 (Reuters) - Wall Street's main indexes closed lower on Friday after Federal Reserve Chair Jerome Powell pointed to a slower pace of interest-rate cuts and investors reacted to cabinet selections by U.S. President-elect Donald Trump.
A
H
M
M
N
P
P
U
U
L

Wall St sinks on Powell rate-cut caution, Trump cabinet picks

US STOCKS-Wall St sinks on Powell rate-cut caution, Trump cabinet picks Retail sales rise 0.4% in October, above forecasts Indexes on track for weekly losses Vaccine makers, packaged food cos fall after RFK Jr. appointment Applied Materials down after Q1 rev forecast misses estimates Indexes down: Dow 0.73%, S&P 500 1.41%, Nasdaq 2.36% Updated prices at 3:03 p.m ET/ 2003 GMT By Sinéad Carew and Lisa Pauline Mattackal Nov 15 (Reuters) - The Nasdaq and S&P 500 were set for their biggest daily los
A
M
M
N
P
P
U
U
L

Drugmaker stocks slide as Trump taps vaccine skeptic RFK Jr for US health job

UPDATE 7-Drugmaker stocks slide as Trump taps vaccine skeptic RFK Jr for US health job Vaccine skepticism concerns impact biotech investor sentiment Shares of European drug makers fall, along with U.S. companies Analysts worry about RFK Jr.'s influence on HHS agencies Updates throughout with detail on stock moves By Samuel Indyk and Ludwig Burger Nov 15 (Reuters) - Shares of major U.S.
A
G
M
P
P
R
S
C
K
C

Monster Beverage Corp reports results for the quarter ended September 30 - Earnings Summary

Monster Beverage Corp reports results for the quarter ended September 30 - Earnings Summary Monster Beverage Corp MNST.OQ reported quarterly adjusted earnings of 38 cents​​ per share for the quarter ended September 30, lower than the same quarter last year, when the company reported EPS of 41 cents. The mean expectation of nineteen analysts for the quarter was for earnings of 43 cents per share.
M

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.